Independent Franchise Partners Llp buys $422,730,843 stake in Monsanto Company (MON)

Monsanto Company (MON) : Independent Franchise Partners Llp scooped up 255,465 additional shares in Monsanto Company during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 3, 2016. The investment management firm now holds a total of 4,050,698 shares of Monsanto Company which is valued at $422,730,843.Monsanto Company makes up approximately 4.38% of Independent Franchise Partners Llp’s portfolio.

Other Hedge Funds, Including , Great West Life Assurance Co Can boosted its stake in MON in the latest quarter, The investment management firm added 72,669 additional shares and now holds a total of 427,427 shares of Monsanto Company which is valued at $44,606,282. Monsanto Company makes up approx 0.13% of Great West Life Assurance Co Can’s portfolio.Sol Capital Management Co reduced its stake in MON by selling 250 shares or 5.42% in the most recent quarter. The Hedge Fund company now holds 4,360 shares of MON which is valued at $465,517. Monsanto Company makes up approx 0.14% of Sol Capital Management Co’s portfolio.Wealthtrust-arizona reduced its stake in MON by selling 101 shares or 20.16% in the most recent quarter. The Hedge Fund company now holds 400 shares of MON which is valued at $42,272. Monsanto Company makes up approx 0.03% of Wealthtrust-arizona’s portfolio. Cribstone Capital Management added MON to its portfolio by purchasing 83 company shares during the most recent quarter which is valued at $8,861. Monsanto Company makes up approx 0.01% of Cribstone Capital Management’s portfolio.Grassi Investment Management boosted its stake in MON in the latest quarter, The investment management firm added 2,192 additional shares and now holds a total of 40,100 shares of Monsanto Company which is valued at $4,055,313. Monsanto Company makes up approx 0.75% of Grassi Investment Management’s portfolio.

Monsanto Company closed down -0.18 points or -0.17% at $106.75 with 13,66,678 shares getting traded on Monday. Post opening the session at $107.5, the shares hit an intraday low of $106.41 and an intraday high of $107.655 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Monsanto Company reported $2.17 EPS for the quarter, missing the analyst consensus estimate by $ -0.23 based on the information available during the earnings call on Jun 29, 2016. Analyst had a consensus of $2.40. The company had revenue of $4189.00 million for the quarter, compared to analysts expectations of $4487.57 million. The company’s revenue was down -8.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.39 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Monness Crespi & Hardt Upgraded Monsanto Company on Aug 8, 2016 to ” Buy”, Price Target of the shares are set at $130.Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.